Estrogen receptor (ER)-negative tumors represent 20-30% of all breast cancers, with a higher proportion occurring in younger women and women of African ancestry. The etiology and clinical behavior of ER-negative tumors are different from those of tumors expressing ER (ER positive), including differences in genetic predisposition. To identify susceptibility loci specific to ER-negative disease, we combined in a meta-analysis 3 genome-wide association studies of 4,193 ER-negative breast cancer cases and 35,194 controls with a series of 40 follow-up studies (6,514 cases and 41,455 controls), genotyped using a custom Illumina array, iCOGS, developed by the Collaborative Oncological Gene-environment Study (COGS). SNPs at four loci, 1q32.1 (MDM4, P = 2.1 × 10-12 and LGR6, P = 1.4 × 10-8), 2p24.1 (P = 4.6 × 10-8) and 16q12.2 (FTO, P = 4.0 × 10-8), were associated with ER-negative but not ER-positive breast cancer (P > 0.05). These findings provide further evidence for distinct etiological pathways associated with invasive ER-positive and ER-negative breast cancers.

Genome-wide association studies identify four ER negative-specific breast cancer risk loci.

BAGLIETTO, LAURA;CAMPA, DANIELE;
2013-01-01

Abstract

Estrogen receptor (ER)-negative tumors represent 20-30% of all breast cancers, with a higher proportion occurring in younger women and women of African ancestry. The etiology and clinical behavior of ER-negative tumors are different from those of tumors expressing ER (ER positive), including differences in genetic predisposition. To identify susceptibility loci specific to ER-negative disease, we combined in a meta-analysis 3 genome-wide association studies of 4,193 ER-negative breast cancer cases and 35,194 controls with a series of 40 follow-up studies (6,514 cases and 41,455 controls), genotyped using a custom Illumina array, iCOGS, developed by the Collaborative Oncological Gene-environment Study (COGS). SNPs at four loci, 1q32.1 (MDM4, P = 2.1 × 10-12 and LGR6, P = 1.4 × 10-8), 2p24.1 (P = 4.6 × 10-8) and 16q12.2 (FTO, P = 4.0 × 10-8), were associated with ER-negative but not ER-positive breast cancer (P > 0.05). These findings provide further evidence for distinct etiological pathways associated with invasive ER-positive and ER-negative breast cancers.
2013
Garcia Closas, M; Couch, Fj; Lindstrom, S; Michailidou, K; Schmidt, Mk; Brook, Mn; Orr, N; Rhie, Sk; Riboli, E; Feigelson, Hs; Le Marchand, L; Buring, Je; Eccles, D; Miron, P; Fasching, Pa; Brauch, H; Chang Claude, J; Carpenter, J; Godwin, Ak; Nevanlinna, H; Giles, Gg; Cox, A; Hopper, Jl; Bolla, Mk; Wang, Q; Dennis, J; Dicks, E; Howat, Wj; Schoof, N; Bojesen, Se; Lambrechts, D; Broeks, A; Andrulis, Il; Guénel, P; Burwinkel, B; Sawyer, Ej; Hollestelle, A; Fletcher, O; Winqvist, R; Brenner, H; Mannermaa, A; Hamann, U; Meindl, A; Lindblom, A; Zheng, W; Devillee, P; Goldberg, Ms; Lubinski, J; Kristensen, V; Swerdlow, A; Anton Culver, H; Dörk, T; Muir, K; Matsuo, K; Wu, Ah; Radice, P; Teo, Sh; Shu, Xo; Blot, W; Kang, D; Hartman, M; Sangrajrang, S; Shen, Cy; Southey, Mc; Park, Dj; Hammet, F; Stone, J; Veer, Lj; Rutgers, Ej; Lophatananon, A; Stewart Brown, S; Siriwanarangsan, P; Peto, J; Schrauder, Mg; Ekici, Ab; Beckmann, Mw; Dos Santos Silva, I; Johnson, N; Warren, H; Tomlinson, I; Kerin, Mj; Miller, N; Marme, F; Schneeweiss, A; Sohn, C; Truong, T; Laurent Puig, P; Kerbrat, P; Nordestgaard, Bg; Nielsen, Sf; Flyger, H; Milne, Rl; Perez, Ji; Menéndez, P; Müller, H; Arndt, V; Stegmaier, C; Lichtner, P; Lochmann, M; Justenhoven, C; Ko, Yd; Gene ENvironmental, Interaction; breast CAncer, Network; Muranen, Ta; Aittomäki, K; Blomqvist, C; Greco, D; Heikkinen, T; Ito, H; Iwata, H; Yatabe, Y; Antonenkova, Nn; Margolin, S; Kataja, V; Kosma, Vm; Hartikainen, Jm; Balleine, R; Kconfab, Investigators; Tseng, Cc; Berg, Dv; Stram, Do; Neven, P; Dieudonné, As; Leunen, K; Rudolph, A; Nickels, S; Flesch Janys, D; Peterlongo, P; Peissel, B; Bernard, L; Olson, Je; Wang, X; Stevens, K; Severi, G; Baglietto, Laura; Mclean, C; Coetzee, Ga; Feng, Y; Henderson, Be; Schumacher, F; Bogdanova, Nv; Labrèche, F; Dumont, M; Yip, Ch; Taib, Na; Cheng, Cy; Shrubsole, M; Long, J; Pylkäs, K; Jukkola Vuorinen, A; Kauppila, S; Knight, Ja; Glendon, G; Mulligan, Am; Tollenaar, Ra; Seynaeve, Cm; Kriege, M; Hooning, Mj; van den Ouweland, Am; van Deurzen, Ch; Lu, W; Gao, Yt; Cai, H; Balasubramanian, Sp; Cross, Ss; Reed, Mw; Signorello, L; Cai, Q; Shah, M; Miao, H; Chan, Cw; Chia, Ks; Jakubowska, A; Jaworska, K; Durda, K; Hsiung, Cn; Wu, Pe; Yu, Jc; Ashworth, A; Jones, M; Tessier, Dc; González Neira, A; Pita, G; Alonso, Mr; Vincent, D; Bacot, F; Ambrosone, Cb; Bandera, Ev; John, Em; Chen, Gk; Hu, Jj; Rodriguez Gil, Jl; Bernstein, L; Press, Mf; Ziegler, Rg; Millikan, Rm; Deming Halverson, Sl; Nyante, S; Ingles, Sa; Waisfisz, Q; Tsimiklis, H; Makalic, E; Schmidt, D; Bui, M; Gibson, L; Müller Myhsok, B; Schmutzler, Rk; Hein, R; Dahmen, N; Beckmann, L; Aaltonen, K; Czene, K; Irwanto, A; Liu, J; Turnbull, C; Familial Breast Cancer, Study; Rahman, N; Meijers Heijboer, H; Uitterlinden, Ag; Rivadeneira, F; Australian Breast Cancer Tissue Bank, Investigators; Olswold, C; Slager, S; Pilarski, R; Ademuyiwa, F; Konstantopoulou, I; Martin, Ng; Montgomery, Gw; Slamon, Dj; Rauh, C; Lux, Mp; Jud, Sm; Bruning, T; Weaver, J; Sharma, P; Pathak, H; Tapper, W; Gerty, S; Durcan, L; Trichopoulos, D; Tumino, R; Peeters, Ph; Kaaks, R; Campa, Daniele; Canzian, F; Weiderpass, E; Johansson, M; Khaw, Kt; Travis, R; Clavel Chapelon, F; Kolonel, Ln; Chen, C; Beck, A; Hankinson, Se; Berg, Cd; Hoover, Rn; Lissowska, J; Figueroa, Jd; Chasman, Di; Gaudet, Mm; Diver, Wr; Willett, Wc; Hunter, Dj; Simard, J; Benitez, J; Dunning, Am; Sherman, Me; Chenevix Trench, G; Chanock, Sj; Hall, P; Pharoah, Pd; Vachon, C; Easton, Df; Haiman, Ca; Kraft, P.
File in questo prodotto:
File Dimensione Formato  
ICOGs ERneg.pdf

solo utenti autorizzati

Tipologia: Versione finale editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 530.86 kB
Formato Adobe PDF
530.86 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/458484
Citazioni
  • ???jsp.display-item.citation.pmc??? 253
  • Scopus 327
  • ???jsp.display-item.citation.isi??? 316
social impact